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ABSTRACT
Background: Antimicrobial resistance has become a worldwide issue as the number of multidrug-resistant (MDR) bacteria has risen considerably. The irrational use of antibiotics contributes
significantly to this issue. Methods: A prospective study was conducted over three months at a
teaching hospital in surgical and medical intensive care units (SICU, MICU) in Palestine. Antimicrobial consumption data were recorded and analyzed using the antimicrobial consumption tool.
Microorganisms and their resistance patterns were obtained from the microbiology laboratory. Results: One hundred patients with a median age of 50 years were included in this study (65% males).
More than half of the patients were admitted to the MICU (55 patients). Vancomycin, piperacillintazobactam, and fluconazole were the most highly consumed antimicrobials, in terms of defined
daily dose(DDD)/100-bed day, in the SICU (37, 31, and 27, respectively). On the other hand,
meropenem, vancomycin, and levofloxacin were the most commonly consumed antimicrobials in
the MICU (49, 35, and 26, respectively). The most frequent organisms were Coagulase-negative
Staphylococci species, Escherichia coli, and Enterococcus faecalis (15%, 12%, and 9%, respectively). There were two Vancomycin-resistant Enterococcus faecium (VRE) cases in each ICU. Methicillin-resistant Staphylococcus aureus (MRSA) was common in the MICUs (five isolates). In both
ICUs, A. baumannii, Escherichia coli, P. aeruginosa, and Klebsiella pneumonia showed extensive
resistance to the tested antibiotics. The isolated Enterococcus faecium from both ICUs were highly
resistant to the commonly used antibiotics. Conclusion: This study revealed high consumption of
the most potent antibiotics and the prevalence of multidrug-resistant organisms (MDRO) in the
tested ICUs. This highlights the need to adhere to the antibiotic stewardship policy to use antibiotics appropriately and reduce the presence of these MDROs.
KEYWORDS: Antimicrobial consumption, antimicrobial resistance, ICU, DDD/100 bed
days, Palestine.
in infants and people aged 65 years or older
INTRODUCTION
(1). In a different study, infections related to
Antimicrobial resistance is one of the
antibiotic-resistant bacteria were associated
biggest and most serious public health chalwith an increased length of stay in the pediatlenges. It poses a heavy burden on health
ric intensive care unit after the onset of infecservices as it increases morbidity, mortality,
tion and increased mortality (2).
and hospital stay and even leads to high ecoThe highest percentage of resistance was
nomic loss at both the individual and govrecorded in intensive care units (ICUs),
ernmental levels. Data from European Antireaching the level of 52.2% multi-drug remicrobial Resistance Surveillance Network
sistant organisms (MDRO) and 18.8% exten2015 showed that 671689 infections were
sively drug-resistant organisms (XDRO) of
due to antibiotic-resistant bacteria. These
the isolate (3). This is because critically ill
infections accounted for an estimated 33110
patients have a 5 to 7 times higher risk for
attributable deaths and 874541 disabilitydeveloping nosocomial infections than ward
adjusted life-years. The burden was highest
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patients. Furthermore, they have an increased
risk of being exposed to invasive devices and
immunosuppressive drugs and consuming
more antibiotics. The pattern of microorganism resistance is different among various
countries and hospitals and even in the ICUs
of the same hospital (4) (1).
Human misuse and abuse of drugs have
certainly played a significant role in making
microorganisms reach a dangerous and lifethreatening resistance level. However, antibiotics are the most commonly prescribed
drugs to patients, mainly in ICU and surgical
departments (5,6). The most common organisms responsible for drug resistance are Acinetobacter bumannii, Klebsiella pneumoniae,
Staphylococcus aureus, and Pseudomonas
aeruginosa. The outer membrane lipid layer
in gram-negative bacteria acts as a permeability barrier that prevents antibiotics from
entering and acting on these bacteria (7). This
progress of antimicrobial resistance can be
slowed down by more rational use of antibiotics, health care regulations, and the restriction of unnecessary perioperative antimicrobial prescriptions. Furthermore, infection
control in health care settings has shown its
efficacy in decreasing resistance (8). Another
effective way to reduce this outgrowing problem is through mass media campaigns to reduce the over-prescription and the threats of
high antimicrobial consumption (9).
The objective of this study was to assess
antimicrobial consumption and bacterial resistance patterns in patients admitted to the
medical and surgical ICUs at a university
teaching hospital in the West Bank, Palestine.
METHODS
An observational prospective cohort
study was carried out in the medical and surgical intensive care units (MICU and SICU)
of a teaching hospital in Nablus. This hospital is one of the leading tertiary referral centers in Palestine; it has 107 beds with two
separate 6-bedded SICU and five bedded
MICU and the study period extended from
Nov 1, 2019, until Feb 3, 2020. Patients were
identified by daily visits to the ICUs and followed from the day of admission to recovery,
discharge, or death. All patients admitted to
the ICUs were included in the study except
those who stayed for less than one hour or

were under 18 years of age. Patients who
were readmitted to the ICU were excluded.
Study setting: The patient's sociodemographic data such as sex, age, as well as
information about the prescribed antimicrobial, dose, grams per unit dosage, number of
doses per package, number of packages consumed, routes of administration of the antimicrobial, length of stay in the hospital and
clinical outcome were obtained from the case
record forms of each ICU. All specimens
such as blood, urine, tracheal aspiration,
wound, and others (fluids, tissue, and sputum) were considered as indicated based on
the clinical suspicion of the treating physician, and they were referred to the Microbiology laboratory for culture and sensitivity.
Bacterial identification and antibiotic susceptibility were determined using the Vitek2
Compact
(bioMérieux,
Marcy-l'Étoile,
TM
France). WHONET 5.6 was used to calculate data on antimicrobial resistance. Colistin
sensitivity analysis was done using the broth
microdilution method, which is the approved
method for determining colistin resistance
analysis according to the Clinical and Laboratory Standards Institute (CLSI)(10). Resistance to at least one agent in three or more
antimicrobial categories was recognized as
multidrug-resistant (MDR). In comparison,
resistance to at least one agent in all antimicrobial categories was considered as extensively drug-resistant (XDR), and resistance to
all antimicrobials in all categories was identified as pan drug-resistant (PDR) (11).
The antimicrobials were arranged according to the ATC system (Anatomical therapeutic chemical classification system). The
antimicrobial consumption patterns of both
medical and surgical units were compared
using a defined daily dose (DDD/100-bed
day). Antimicrobial consumption was calculated using the Antimicrobial Consumption
tool (AMCtool 2019) (12). Antimicrobial
information such as name, pack size,
strength, route of administration, and the
number of packages was assigned to the program, and the number of bed-days was applied as the denominator of each ICU as calculated from the case record forms.
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No. of bed day = No. of beds in ICU ×
Occupancy index × No. of days (during the
study period)
Definitions: Defined daily dose (DDD,
expressed in grams) was defined as the average maintenance dose per day for a drug used
for its main indication in a 70 kg adult, as per
the world health organization and Anatomical Therapeutic Chemical (ATC) definition
of a specific DDD. A bad day is a day during
which a person is confined to a bed and in
which the patient stays overnight in a hospital. Day cases are sometimes included as onebed days and sometimes excluded (13).
Statistical Analysis: Collected data were
tabulated and analyzed using Statistical
Package for Social Sciences (SPSS), Version
21.0 (IBM Corporation, Armonk, NY,
USA).).

RESULTS
Socio-demographic data: A total of one
hundred patients were included in this study;
55 were admitted to the SICU and 45 to the
medical ICU. The total bed days in the SICU
were 362 with an occupancy index of 64%,
while 340.5 in the MICU with an occupancy
index of 72%. Among the SICU patients,
37(67%) were males with a median age of 46
years. About 58% of the patients were under
50 years, and their median age was 32. Those
admitted to the MICU included 28 (62%)
males with a median age of 57 years. About
42% of the patients were under 50 years old,
and their median age was 35. During the
study period, 15 patients died in the MICU,
and 9 died in the SICU. The number of
deaths due to infections in the MICU was
eight (33.3%) and in the SICU was one
(1.1%). (Table 1).

Table (1): Characteristics of medical and surgical ICU.
Number of beds
Number of admitted patients
Number of admitted patients Less than
50 years
Median age
Sex (Male)
Total Bed days
Occupancy (%)
Number of deaths
Causes of deaths
• Infectious
• Non-infectious

MICU
5
45

SICU
6
55

19

32

57
28
340.5
72
15 (33.3)

46
37
362
64
9(10.9)

8(53.3)
7(46.6)

Antimicrobial consumption: The average number of drugs prescribed was about
three per patient in both SICU and MICU,
with 145 and 142 prescriptions in the SICU
and MICU. The most commonly prescribed
antimicrobials in the SICU were vancomycin
[27(18.6%)] followed by piperacillintazobactam [25 (17.2%)]; while meropenem
[25(17.6%)] and vancomycin [24(16.9%)]
were the most commonly prescribed in the
MICU. Fifteen patients did not receive anti-

Total
11
100
51

24

1(1.1)
9
8(8.9)
15
microbials in the surgical unit compared to
only four patients in the medical unit. (Table
2) demonstrates the number of antimicrobials
prescribed to patients in each ICU. Patients
who received one or two antibiotics were
31% in both ICUs, and those who received
three or more were 42% and 60% of total
patients in the surgical and medical units,
respectively.
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Table (2): Antimicrobials prescribed for patients in each ICU.
MICU
SICU
N (%)
N (%)
Carbapenems
25 (17.6)
10 (6.9)
Vancomycin
24 (17)
27 (18.6)
Fluoroquinolones
16 (11.3)
21 (14.5)
Bate-lactam/beta-lactamase inhibitors
15 (10.6)
25 (17.2)
Colistin
12 (8.5)
6 (4.1)
Cephalosporins
10 (7)
18 (12.4)
Tigecycline
10 (7)
1 (0.7)
Aminoglycosides
9 (6.3)
17 (11.7)
Trimethoprim-sulfamethoxazole
5 (3.5)
0
Macrolides
4 (2.8)
4 (2.8)
Metronidazole
1 (0.7)
5 (3.5)
Doxycycline
0
1 (0.7)
Rifaximin
0
1 (0.7)
Antifungal
11 (7.7)
9 (6.2)
Total
142
145
were meropenem, followed by vancomycin
The surgical unit's most commonly conand levofloxacin (49, 35, and 26 respectivesumed antibiotic (DDD/100-bed day) was
ly), while the least used antimicrobials were
vancomycin, followed by piperacillinmetronidazole and cefazolin (<1). (Table Ertazobactam and fluconazole (37, 31, and 27,
ror! Reference source not found.3) comrespectively). Cefuroxime was the least conpares the antimicrobial consumption in both
sumed antimicrobial (<1). The most comthe medical and surgical units.
monly consumed antimicrobials in the MICU
Antimicrobial

Table (3): Antimicrobial consumption (DDD/100 patient-days)in both ICUs.

Antimicrobial agent

ATC code

WHO
DDD
(g)

Amoxicillin-clavulanate
Piperacillin-tazobactam
Cefazolin
Cefuroxime
Ceftriaxone
Cefotaxime
Ceftazidime
Meropenem
Ciprofloxacin
Levofloxacin
Vancomycin
Gentamycin
Amikacin
Erythromycin
Clindamycin
Azithromycin
Doxycycline
Tigecycline
Colistin

J01CR02
J01CR05
J01DB04
J01DC02
J01DD04
J01DD01
J01DD02
J01DH02
J01MA02
J01MA12
J01XA01
J01GB03
J01GB06
J01FA01
J01FF01
J01FA10
J01AA02
J01AA12
J01XB01

3
14
3
3
2
4
4
3
0.8
0.5
2
0.24
1
1
1.8
0.5
0.1
0.1
9 MU

DDD/100 bed days
SICU
2.58
31.57
2.3
0.69
1.38
1.59
12.15
13.72
4.28
19.06
37.15
1.93
10.36
2.49
3.31
5.52
1.93
2.58

MICU
17.96
0.1
3.23
1.1
2.42
49.34
0.73
25.99
35.1
1.37
6.9
2.94
2.06
25.4
10.7
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Antimicrobial agent

WHO
DDD

ATC code

(g)
Metronidazole
Trimethoprim/sulfamethoxazole
Rifaximin
Fluconazole
Voriconazole
Amphotericin B
Caspofungin
Total

J01XD01
J01EE01
A07AA11
J02AC01
J02AC03
J02AA01
J02AX04

Microbiologic results and resistance
patterns: One hundred eighty-one specimens
were obtained from 38 patients in the SICU;
55 cultures were tested positive in 18 patients. Error! Reference source not
found.The total number of isolates in the
SICU was 55; 25 (46%) gram-negative bacteria, 26 (47%) gram-positive bacteria, and 4
(7%) Candida spp. The most frequent gramnegative organisms were Escherichia coli
with 9 (36%) and Acinetobacter baumannii
with 7 (28%). On the other hand, Coagulasenegative Staphylococcus spp ([11; (42%)],
Enterococcus spp [(12; (46%)] and Staph.
aureus [3; (11.5)] were the most commonly
isolated bacteria among gram-positive isolates. (Table 4).

1.5
4 UD
0.6
0.2
0.4
35mg
50 mg

DDD/100 bed days
SICU
2.95
15.19
27.35
1.58
201.66

MICU
0.49
13.8
3.08
14.98
1.47
219.16

The number of collected specimens from
the MICU was 278 from 37 patients; 78 cultures were positive in 27 patients. Of the total
78 isolates, there were 22(28%) gramnegative bacteria, 31 (40%) gram-positive
bacteria, and 25 (32%) Candida spp. Escherichia coli (7; 32%) and Klebsiella pneumonia (5; 23%) were the most common gramnegative pathogens. Enterococcus spp (12;
39%), Coagulase-negative Staphylococcus
spp (9; 29%), and Staphylococcus aureus (7;
23%) were the most common gram-positive
bacteria. Candida isolates were included only
from blood, urine, and tracheal aspirates in
SICU and MICU. (Table 4).

Table (4): Frequency of isolated organisms from both ICUs.
Microorganism
Gram Negative organisms
E. coli
Klebsiellapneumoniae
Acinetobacterbaumannii
Enterobacter cloacae
Pseudomonas aeruginosa
Others
Gram Positive organisms
Enterococcus faecalis
Enterococcus faecium
Staph. aureus (MRSA)
Staph. aureus (MSSA)
Coagulase negative Staph.
Others
Candida species
Candida glabrata
C. albicans

MICU
N (%)
22 (28)
7 (31.8)
5 (22.7)
2 (9.1)
2 (9.1)
2 (9.1)
4 (18)
31 (40)
7 (22.6)
5 (16.1)
5 (16.1)
2 (6.5)
9 (29)
3 (9.6)
25 (32)
9 (36)
7(28)

SICU
N (%)
25 (46)
9 (36)
2 (8)
7 (28)
2 (8)
2 (8)
3 (12)
26 (47)
5 (19.2)
4 (15.4)
2 (7.7)
1 (3.84)
11(42.3)
3 (11.5)
4 (7)
1 (25)
1 (25)

Total
N (%)
47 (35.3)
16 (12)
7 (5.3)
9 (6.8)
4 (3)
4 (3)
7 (5.3)
57 (42.9)
12 (9)
9 (6.8)
7 (5.3)
3 (2.3)
20 (15)
6 (4.5)
29 (21.8)
10 (7.5)
8 (6)
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MICU
SICU
Total
N (%)
N (%)
N (%)
9 (36)
2 (50)
11 (8.3)
78 (58.6)
55 (41.4)
133 (100)
SICU, where 66.6% of E.coli, 86% of
A.baumannii, 100% of K.pneumonia, 88% of
Enterococcus were MDRs, and two-thirds of
S.aureus were MRSA.

Microorganism
Other Candida spp
Total number of isolates
The resistance patterns of gram-negative
and gram-positive microorganisms are illustrated in (Tables 5 and 6) for both ICUs, respectively. MDRs are highly present in the

Table (5): Antibiotic resistance of gram-negative bacteria.

ICU (no of isolates)
Amoxicillin/Clavulanic acid
Ceftazidime
Cefotaxime
Ceftriaxone
Cefepime
Piperacillin/Tazobactam
Meropenem
Amikacin
Gentamicin
Ciprofloxacin
Trimethoprim/Sulfamethoxazole
Tigecycline
Tetracycline

0
0
0
0
0
0

K. pneumoniae
MIC
SIC
U (5) U (2)
60
100
60
100
100
60
100
60
100
60
100
20
100
20
100
20
100
60
100

MIC
U (7)
14
57
57
57
57
0
0
0
29
29

SIC
U (9)
78
78
78
78
67
33
11
22
11
33

-

-

40

100

14

56

-

-

-

0
0

-

0

A. baumannii

P. aeruginosa

MIC
U (2)
100
100
100
100
100
-

SIC
U (7)
86
86
86
86
86
-

MIC
U (2)
-

SIC
U (2)
-

100
50
100
100
100
-

100

57

-

-

E. coli

Table (6): Antibiotic resistance of gram-positive bacteria.
E.faecalis
E.faecium
S.aureus
MICU
SICU
MICU
SICU
MICU
SICU
(7)
(5)
(5)
(4)
(7)
(3)
Amoxicillin/Clavulanic acid
14
0
100
100
71
67
Oxacillin
71
67
Cefuroxime
71
67
Erythromycin
100
100
100
50
43
67
Clindamycin
29
67
Vancomycin
0
0
40
50
0
0
Tetracycline
100
80
60
50
14
67
Doxycycline
0
0
0
0
0
Tigecycline
0
0
0
0
0
0
Ciprofloxacin
57
80
100
100
29
0
Levofloxacin
57
80
100
100
29
0
Rifampin
0
0
Gentamicin
71
80
100
75
0
0
Trimethoprim/Sulfamethoxazole
29
0
spp were MDR. Seventy-one percent of
In the medical ICU, 28% of E.coli, 60%
S.aureus were MRSA. Moreover, 4 out of 9
of K.pneumonia, all isolates of A.baumannii
(44%) urinary isolates of Candida glabrata
and P.aeruginosa, and 75% of Enterococcus
Antibiotic/ ICU (no of isolates)
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in the medical ICU were voriconazoleresistant.
DISCUSSION
The increased consumption of antimicrobials is a major cause of the increased incidence of MDRO. ICU patients are prescribed antimicrobials more often than any
other wards in the hospital (4) because these
patients are severely ill, and the empirical use
of antimicrobials is more frequent. We conducted this observational cohort study in both
medical and surgical ICUs at a teaching hospital in Palestine to assess the antimicrobial
consumption, frequency of microorganisms,
and antimicrobial resistance patterns in each
ICU.
A total of 20 antimicrobial agents were
used in the medical ICU, and 22 drugs were
used in the surgical unit. Among the 145 prescriptions made in the surgical unit, vancomycin was the most commonly prescribed,
followed by beta-lactam/beta-lactamases and
cephalosporins. Carbapenems were the most
commonly prescribed for the medical ICU,
followed by vancomycin. The highest consumption in the surgical unit was for vancomycin (37) and piperacillin-tazobactam (32),
and fluconazole (27). Among the medical
unit, the highest were meropenem (49) and
vancomycin (35). A similar result was reported in Saudi Arabia in 2018, where the
consumption of carbapenems, piperacillin/tazobactam, vancomycin, and colistin
were the most commonly consumed antimicrobials in five adult ICUs (14). Alone et al.
in 2019 reported that ceftriaxone, imipenem,
and vancomycin were the most highly consumed antimicrobials in intensive care units
at North West (Tabuk) hospitals, Saudi Arabia (14). Cephalosporins and carbapenems
were most frequently prescribed in adult
ICUs in Jordan (15). In 2013, the most prescribed antibiotic in intensive care units of
Tabriz Imam Reza hospital was the cephalosporin family, and ceftriaxone was the most
utilized antibiotic (16). In Turkey, the most
frequently prescribed antibiotics were firstgeneration cephalosporins (16.1%), thirdgeneration cephalosporins (15.2%), aminoglycosides (12.1%), carbapenems (10.7%)
and ampicillin-sulbactam (8.7%)(17). In a
more recent report from Asmara, Eritrea,

benzylpenicillin was the most consumed antibiotic, and ceftriaxone and ciprofloxacin
were among the most commonly consumed
antibiotics in both hospitals (18). In a study
conducted in India to assess antibiotic consumption in the ICU of a tertiary care hospital, the authors found that metronidazole was
the most highly consumed antimicrobial
[100.9], followed by fluconazole [76.6] and
levofloxacin [62.7](4). In Oman, the most
commonly prescribed antimicrobials were the
antipseudomonal penicillin (piperacillin in
combination with beta-lactam tazobactam)
31%; followed by cephalosporins 17%,
meropenem 11%, macrolides 15%, and quinolones 10% (19). This antimicrobial consumption was low compared with the New
Delhi study and Oman (3,20).
The high vancomycin consumption
could be due to the empirical use in both
ICUs and the ease of ordering this antibiotic
in the hospital; moreover, high resistance
rates could be attributed to the high consumption of antibiotics. Similar results were
reported by an Israeli study where vancomycin and imipenem were among the most consumed antibiotics (21). In contrast, in the
New Delhi study, the consumption of metronidazole and fluconazole was the highest,
while vancomycin consumption was the lowest (4). In both the medical and surgical
ICUs, there was a very high level of extended-spectrum beta-lactamases (ESBL) producers among gram-negative bacilli, and beta-lactams had a high consumption, especially in the medical ICU where carbapenems
were prescribed to 55% of the patients. They
were the most commonly prescribed antimicrobials in the medical ICU. This high prescription would result in resistant bacteria,
leading to treatment failure; therefore, this
class of antimicrobials should be cultureguided because carbapenems are potent inducers of class C beta-lactamases could explain the high resistance to beta-lactams
(4,22,23). Similar results were seen in the
NewDelhi and Omani studies (4,20).
Furthermore, in the surgical ICU, gramnegative bacilli were highly resistant to
amoxicillin-clavulanic acid and piperacillintazobactam (84%, 52%, respectively), and
beta-lactam/beta-lactamases were prescribed
to 45% of the patients. This may result in
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treatment failure due to the high resistance
among gram-negative bacilli. Vancomycin
was the most commonly prescribed drug in
the surgical ICU, given to 49% of the patients.
Candida spp in the medical ICU (30% of
the total isolates) was higher than in the surgical ICU (7% of the total isolates), and the
most common species was Candida glabrata.
This might be due to the empirical use of fluconazole in the surgical ICU with a
DDD/100-bed day of 27 compared with three
for fluconazole and 14 for voriconazole in
the medical ICU.
In the surgical ICU, E.coli and
A.baumannii were the most common organisms, and most of these isolates were MDR;
more than half of S.aureus isolates were
MRSA, while the most commonly isolated
organisms in the MICU were S.aureus and
Enterococcus spp and most of the Enterococci were MDR and majority of S.aureus were
MRSA. In the New Delhi study, the most
common microorganisms isolated in the surgical ICU were S.aureus and K.pneumonia,
and most of them were MDR, while 60% of
S.aureus was MRSA(4). Another study from
DhakaBangladesh,
showed
that
P.aeruginosa (29%) and Acinetobacter spp
(27%) were the most commonly isolated in
the general ICU and the majority of these
isolates were MDR (77%) of S.aureus were
MRSA (22). In European ICUs, the most
common isolated organisms were S.aureus
(30%) and P.aeruginosa (28%) (24). In a
study conducted in the Sultanate of Oman,
the most common organisms were
P.aeruginosa (21%) and K.pneumonia (20%)
(22). S.aureus and K.pneumonia were the
most frequently isolated in a Romanian
study, with 53% of S.aureus being MRSA
(25). Half of the isolates were MDR on both
surgical and medical units. This is similar to
a study conducted in India which showed that
52% of the total isolates taken from general
ICUs were MDR, and this was significantly
higher than the ward results, which showed a
lower percentage of MDR (11).
In the surgical ICU, the most common
isolates from blood cultures were Coagulasenegative staph, while A. baumannii, E.coli,
and Enterococcus spp were the most com-

mon in urine. Staph. Aureus was the most
common in tracheal aspirations.
In the medical ICU, Coagulase-negative
staphylococcal species and K.pneumonia
were the most common in blood; Candida
glabrata and E.coli were the most common
in urine. Candida albicans and S.aureus were
the most common in tracheal aspirations.
Rambam Hospital in Haifa, Israel, reported
that P. aeruginosa and Acinetobacter spp
were the most commonly isolated organisms
from blood (23). Another study in Romania
showed that the most commonly isolated organisms were candida, E. coli, and S. aureus
of blood, urine, and tracheal aspirations, respectively (25).
CONCLUSION
This study showed a difference in the
frequency of organisms in the medical and
surgical ICUs, and antimicrobial consumption was high. Antimicrobials of last resort,
such as tigecycline, meropenem, and vancomycin, were highly consumed in the medical
ICU. This highlights the need to adhere to the
antibiotic stewardship policy to use antibiotics appropriately and reduce the incidence of
these MDROs in Palestine.
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